Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Collegium Pharmaceutical Inc shares valued at $171,673 were purchased by RITA BALICE-GORDON on Dec 05 ’25. At $47.03 per share, RITA BALICE-GORDON acquired 3,650 shares.
Also, Dreyer Scott sold 17,600 shares, netting a total of over 847,855 in proceeds. Following the sale of shares at $48.17 each, the insider now holds 103,613 shares.
Before that, Balice-Gordon Rita J. had sold 3,650 shares from its account. In a trade valued at $171,673, the Director traded Collegium Pharmaceutical Inc shares for $47.03 each. Upon closing the transaction, the insider’s holdings decreased to 3,650 shares, worth approximately $2.44 million.
As published in their initiating research note from Barclays on December 09, 2025, Collegium Pharmaceutical Inc [COLL] has been an Overweight and the price target has been revised to $58. Analysts at Needham upgraded the stock from ‘”a Hold”‘ to ‘”a Buy”‘ outlook in a report released in early January. As of July 30, 2024, H.C. Wainwright has increased its “Neutral” rating to a “Buy” for COLL. Earlier on June 07, 2024, Jefferies upgraded its rating. Their new recommendation was “a Buy” for COLL stock which previously was a “a Hold”.
Analyzing COLL Stock Performance
On last trading session, Collegium Pharmaceutical Inc [NASDAQ: COLL] plunged -1.76% to $46.3. The stock’s lowest price that day was $45.84, but it reached a high of $47.435 in the same session. During the last five days, there has been a drop of approximately -5.22%. Over the course of the year, Collegium Pharmaceutical Inc shares have jumped approximately 59.05%. Shares of the company reached a 52-week high of $50.79 on 12/29/25 and a 52-week low of $23.23 on 04/10/25.
Support And Resistance Levels for Collegium Pharmaceutical Inc (COLL)
According to the 24-hour chart, there is a support level at 45.59, which, if violated, would cause prices to drop to 44.88. In the upper region, resistance lies at 47.22. The next price resistance is at 48.15. RSI (Relative Strength Index) is 44.52 on the 14-day chart, showing neutral technical sentiment.
Is Collegium Pharmaceutical Inc subject to short interest?
Stocks of Collegium Pharmaceutical Inc saw a sharp steep in short interest on 2025-12-15 dropping by -0.33 million shares to 5.35 million. Data from Yahoo Finance shows that the short interest on 2025-11-14 was 5.68 million shares. A decline of -6.09% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 10.17 of the overall float, the days-to-cover ratio (short ratio) decline to 10.17.
Which companies own the most shares of Collegium Pharmaceutical Inc (COLL)?
In terms of Collegium Pharmaceutical Inc share price expectations, FactSet research, analysts set an average price target of 58 in the next 12 months, up nearly 23.06% from the previous closing price of $47.13. Analysts anticipate Collegium Pharmaceutical Inc stock to reach 58 by 2026, with the lowest price target being 58. In spite of this, 4 analysts ranked Collegium Pharmaceutical Inc stock as Buy at the end of 2026. On May 10, 2024, Piper Sandler assigned a price target of “a Neutral” to the stock and downgraded coverage with a $39.
